71 related articles for article (PubMed ID: 27301112)
1. [CLINICAL AND ENDOSCOPIC, MORPHOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES OF GASTRIC ULCER IN H. PYLORI-INFECTED INDIVIDUALS RECEIVING CYTOTOXIC THERAPY].
Sazonova OV; Davydkin IL; Osadchuk AM; Gritsenko TA
Eksp Klin Gastroenterol; 2016; (2):18-24. PubMed ID: 27301112
[TBL] [Abstract][Full Text] [Related]
2. [Gastroesophageal reflux disease in patients receiving chemotherapy: clinical, endoscopic, morphological and immunohistochemical features].
Gricenko TA; Davydkin IL; Osadchuk AM; Kostalanova JV
Eksp Klin Gastroenterol; 2015; (2):17-23. PubMed ID: 25993868
[TBL] [Abstract][Full Text] [Related]
3. Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis.
Chen LW; Chang LC; Hua CC; Hsieh BJ; Chen SW; Chien RN
BMC Gastroenterol; 2017 Jan; 17(1):1. PubMed ID: 28049442
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
[TBL] [Abstract][Full Text] [Related]
5. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Martín de Argila C
Gastroenterol Hepatol; 2000; 23(6):269-74. PubMed ID: 15324621
[TBL] [Abstract][Full Text] [Related]
6. [Specifics of apoptotic activity and expression of regulatory molecules (Ki-67, Bcl-2) of gastric mucosal epitheliocytes, in the process of Correa's cascade].
Komarov FI; Osadchuk AM; Osadchuk MA; Kogan NIu; Kveshnoĭ IM
Klin Med (Mosk); 2007; 85(10):48-51. PubMed ID: 18154181
[TBL] [Abstract][Full Text] [Related]
7. Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression.
Ierardi E; Francavilla A; Balzano T; Traversa A; Principi M; Monno RA; Amoruso A; Ingrosso M; Pisani A; Panella C
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):214-9. PubMed ID: 9646212
[TBL] [Abstract][Full Text] [Related]
8. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
Kyzekové J; Arlt J; Arltová M
Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of mucosal soluble fas ligand and interferon-gamma may be involved in ulcerogenesis in patients with Helicobacter pylori-positive gastric ulcer.
Shimada M; Ina K; Kyokane K; Imada A; Yamaguchi H; Nishio Y; Hayakawa M; Iinuma Y; Ohta M; Ando T; Kusugami K
Scand J Gastroenterol; 2002 May; 37(5):501-11. PubMed ID: 12059049
[TBL] [Abstract][Full Text] [Related]
10. Th response to Helicobacter pylori differs between patients with gastric ulcer and duodenal ulcer.
Itoh T; Seno H; Kita T; Chiba T; Wakatsuki Y
Scand J Gastroenterol; 2005 Jun; 40(6):641-7. PubMed ID: 16036523
[TBL] [Abstract][Full Text] [Related]
11. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
12. Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers.
Tulassay Z; Stolte M; Engstrand L; Butruk E; Malfertheiner P; Dítê P; Tchernev K; Wong BC; Gottlow M; Eklund S; Wrangstadh M; Herszényi L; Nagy P;
Scand J Gastroenterol; 2010 Sep; 45(9):1048-58. PubMed ID: 20509752
[TBL] [Abstract][Full Text] [Related]
13. Effects of Helicobacter pylori Infection on gastric mucin expression.
Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
[TBL] [Abstract][Full Text] [Related]
14. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
Kyzekova J; Mour J
Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
[TBL] [Abstract][Full Text] [Related]
15. Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
Celinski K; Konturek PC; Konturek SJ; Slomka M; Cichoz-Lach H; Brzozowski T; Bielanski W
J Physiol Pharmacol; 2011 Oct; 62(5):521-6. PubMed ID: 22204799
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer.
Aydemir SA; Tekin IO; Numanoglu G; Borazan A; Ustundag Y
Mediators Inflamm; 2004 Dec; 13(5-6):369-72. PubMed ID: 15770055
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic research of expression and relationship between Helicobacter pylori of c-met oncogene correlation with gastric mucosal proliferation].
Zhuang X; Lin S; Zheng J; Wang L; Sun G; Li Y
Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):381-4. PubMed ID: 11798602
[TBL] [Abstract][Full Text] [Related]
18. Effect of Helicobacter pylori infection, smoking and dietary habits on the occurrence of antrum intestinal metaplasia. Clinico-epidemiological study in Poland.
Jedrychowski W; Popiela T; Drews M; Gabryelewicz A; Marlicz K; Misiunia P; Wajda Z; Matyja A; Nowak K; Ramroth H; Wahrendorf J
Pol J Pathol; 1999; 50(4):289-95. PubMed ID: 10721269
[TBL] [Abstract][Full Text] [Related]
19. [Morphologic changes of gastric mucosa in Helicobacter pylori infection in patients with peptic ulcer disease and chronic gastritis].
Raczyńska A; Jarczyk G; Jarczyk J; Jedrzjczyk W
Pol Merkur Lekarski; 1996 Sep; 1(3):165-8. PubMed ID: 9139779
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.
Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T
Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
